Eli Grong Aursand
Direktor/Vorstandsmitglied bei Nadeno Nanoscience AS
Aktive Positionen von Eli Grong Aursand
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Sintef TTO AS
Sintef TTO AS Investment ManagersFinance Sintef TTO AS is a venture capital firm located in Trondheim, Norway. Sintef TTO is a wholly-owned subsidiary of SINTEF, established in 1950, one of the largest independent research organizations in the Nordic region. Their areas of research encompass information and communications technology, technology management, marine activities, materials science and applied chemistry, health, petroleum, energy, and construction. Sintef TTO, as the group's development firm, is responsible for their innovation activities. They are also the owner and manager of SINTEF's Intellectual Property Rights (IPR). They are the investment manager of several funds, namely SINTEF Venture III AS, Sinvent Venture, and SpinOutVenture II AS. | Private Equity Investor | 01.01.2019 | - |
Nadeno Nanoscience AS
Nadeno Nanoscience AS BiotechnologyHealth Technology Nadeno Nanoscience AS is a company based in Trondheim, Norway. Nadeno is a Sintef spin-off that specializes in nanotechnology drug delivery platforms. The Norwegian company has developed a platform that focuses on unleashing the potential of hard-to-deliver hydrophobic small molecule drugs. The company's technology is designed to address the majority of failures in drug delivery. The company was founded by Annbjørg Falck and Yrr Mørch, with Annbjørg Falck serving as CEO since incorporation. | Direktor/Vorstandsmitglied | 01.08.2022 | - |
Karriereverlauf von Eli Grong Aursand
Statistik
International
Norwegen | 3 |
Operativ
Private Equity Investor | 1 |
Director/Board Member | 1 |
Sektoral
Finance | 2 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Sintef TTO AS
Sintef TTO AS Investment ManagersFinance Sintef TTO AS is a venture capital firm located in Trondheim, Norway. Sintef TTO is a wholly-owned subsidiary of SINTEF, established in 1950, one of the largest independent research organizations in the Nordic region. Their areas of research encompass information and communications technology, technology management, marine activities, materials science and applied chemistry, health, petroleum, energy, and construction. Sintef TTO, as the group's development firm, is responsible for their innovation activities. They are also the owner and manager of SINTEF's Intellectual Property Rights (IPR). They are the investment manager of several funds, namely SINTEF Venture III AS, Sinvent Venture, and SpinOutVenture II AS. | Finance |
Nadeno Nanoscience AS
Nadeno Nanoscience AS BiotechnologyHealth Technology Nadeno Nanoscience AS is a company based in Trondheim, Norway. Nadeno is a Sintef spin-off that specializes in nanotechnology drug delivery platforms. The Norwegian company has developed a platform that focuses on unleashing the potential of hard-to-deliver hydrophobic small molecule drugs. The company's technology is designed to address the majority of failures in drug delivery. The company was founded by Annbjørg Falck and Yrr Mørch, with Annbjørg Falck serving as CEO since incorporation. | Health Technology |
- Börse
- Insiders
- Eli Grong Aursand
- Erfahrung